Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trialNadia Harbeck, Marion van Mackelenbergh, Eva Ciruelos et al.|Nature Medicine|2024Cited by 8
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi studyJürgen Geisler, Sophie Yammeni, Barbro Holm et al.|Acta Oncologica|2023Cited by 6